MYGN
Myriad Genetics, Inc.

2,099
Mkt Cap
$473.53M
Volume
291,334.00
52W High
$15.47
52W Low
$3.76
PE Ratio
-1.17
MYGN Fundamentals
Price
$4.96
Prev Close
$5.08
Open
$5.08
50D MA
$6.33
Beta
1.19
Avg. Volume
918,218.65
EPS (Annual)
-$1.41
P/B
1.27
Rev/Employee
$310,222.22
$1,271.43
Loading...
Loading...
News
all
press releases
Myriad Genetics, Inc. (NASDAQ:MYGN) Given Consensus Rating of "Hold" by Brokerages
Myriad Genetics, Inc. (NASDAQ:MYGN - Get Free Report) has earned a consensus rating of "Hold" from the thirteen ratings firms that are presently covering the company, Marketbeat.com reports. Three...
MarketBeat·6d ago
News Placeholder
More News
News Placeholder
Myriad Genetics (NASDAQ:MYGN) Downgraded by Zacks Research to Strong Sell
Zacks Research downgraded shares of Myriad Genetics from a "hold" rating to a "strong sell" rating in a research note on Monday...
MarketBeat·21d ago
News Placeholder
Myriad Genetics (NASDAQ:MYGN) Stock Price Down 6.5% - Time to Sell?
Myriad Genetics (NASDAQ:MYGN) Trading Down 6.5% - Here's What Happened...
MarketBeat·22d ago
News Placeholder
TEM's Collab for Oncology Patient Population Is Gaining Attention
Tempus AI's partnerships with NYU Langone and Northwestern Medicine aim to expand genomic testing and data-driven cancer care.
Zacks·29d ago
News Placeholder
Myriad Genetics Reports Preliminary Q4 Revenue; Issues 2026 Guidance
(RTTNews) - Myriad Genetics, Inc. (MYGN) said it expects fourth quarter total revenues to be between $207 million and $209 million. Full year 2025 total revenues are projected to be between $822...
Nasdaq News: Markets·1mo ago
News Placeholder
Myriad Genetics (NASDAQ:MYGN) Stock Passes Above 200 Day Moving Average - Here's Why
Myriad Genetics (NASDAQ:MYGN) Share Price Passes Above 200 Day Moving Average - Should You Sell...
MarketBeat·1mo ago
News Placeholder
Should Myriad Genetics Stock Stay in Your Portfolio Right Now?
MYGN shows growth potential from new genetic test launches and a refreshed CCC strategy, but revenue pressure from GeneSight coverage loss remains a drag.
Zacks·1mo ago
News Placeholder
Myriad Genetics (NASDAQ:MYGN) Share Price Passes Above 200-Day Moving Average - Here's Why
Myriad Genetics (NASDAQ:MYGN) Stock Passes Above Two Hundred Day Moving Average - Here's Why...
MarketBeat·1mo ago
News Placeholder
Myriad Genetics, Inc. $MYGN Shares Bought by Assenagon Asset Management S.A.
Assenagon Asset Management S.A. raised its stake in Myriad Genetics, Inc. (NASDAQ:MYGN - Free Report) by 301.2% in the third quarter, according to the company in its most recent disclosure with the...
MarketBeat·2mo ago
News Placeholder
Myriad Genetics, Inc. (NASDAQ:MYGN) Receives Average Recommendation of "Hold" from Brokerages
Myriad Genetics, Inc. (NASDAQ:MYGN - Get Free Report) has received a consensus rating of "Hold" from the fourteen analysts that are presently covering the firm, Marketbeat Ratings reports. Two...
MarketBeat·2mo ago
<
1
2
...
>

Latest MYGN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.